In our study we observed that around 60% of the patients with OSCC had a significantly higher monocyte count than the cut-off value and this correlated with increasing tissue survivin levels, but we did not find any significant variation with respect to tumor staging or node involvement. The gene discussed is BIRC5; the disease is neoplasm.